Last $3.79 USD
Change Today -0.05 / -1.30%
Volume 1.5M
ARRY On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 4:00 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin Koch Ph.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

53$1,058,493
As of Fiscal Year 2013

Background*

Dr. Kevin Koch, Ph.D., is a Co-Founder of Array Biopharma, Inc. and served as its President and Chief Scientific Officer since May 1998 until November 2013. Prior to in Array, Dr. Koch served as an Associate Director of Medicinal Chemistry and Project Leader for the Protease Inhibitor and New Leads project teams from May 1995 to April 1998 for Amgen Inc. From September 1988 until May 1995, Dr. Koch held various positions with Pfizer Central Research, including Senior ...

Read Full Background

Corporate Headquarters*

3200 Walnut Street
Boulder, Colorado 80301

United States

Phone: 303-381-6600
Fax: 303-449-5376

Board Members Memberships*

1998-2012
Co-Founder

Education*

BS
State University of New York
PhD
University of Rochester

Other Affiliations*

Annual Compensation*

Salary$445,000
Total Annual Compensation$445,000

Stock Options*

All Other Compensation$36,415
Exercisable Options600,832
Exercisable Options Value$314,756
Unexercisable Options243,750
Unexercisable Options Value$166,200
Total Value of Options$480,955
Total Number of Options844,582

Total Compensation*

Total Annual Cash Compensation$696,795
Total Short Term Compensation$445,000
Other Long Term Compensation$36,415
Total Calculated Compensation$1,058,493
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARRY:US $3.79 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
Cell Therapeutics, Inc.
$1.3M
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, President, Chairman of Placement Committee and Chairman of Product Acquisition Committee
Spectrum Pharmaceuticals, Inc.
$2.4M
Aijaz Tobaccowalla Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee
Wyeth Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARRAY BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.